MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202641107147 A) filed by Ambit-N Lifesciences; Sanjith Mooppil; Shency Thomas; Aleena Johny; and Ameena K. S. on September 06, 2026, for A Standardized Composition Of Curcuma Longa And Cuminum Cyminum Extracts And Process For Preparation Thereof.
Inventors include Ambit-N Lifesciences; Sanjith Mooppil; Shency Thomas; Aleena Johny; and Ameena K. S..
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: A Standardized Composition of Curcuma longa and Cuminum cyminum Extracts and Process for Preparation Thereof The present invention relates to a standardized botanical composition comprising Curcuma longa rhizome extract and Cuminum cyminum seed extract, wherein the Curcuma longa extract is present in an amount of 200 to 300 mg/capsule and standardized to 90 to 98% w/w total curcuminoids, the Cuminum cyminum extract is present in an amount of 200 to 300 mg/capsule, and the extracts are present in a ratio of 0.67 : 1 to 1.5 : 1, with a total botanical extract content of 450 to 550 mg/capsule, prepared by separate hydroalcoholic extraction, filtration, concentration, drying and controlled blending of the extracts. A preferred 500 mg capsule comprises 250 mg of 95% curcumin-standardized Curcuma longa extract and 250 mg of Cuminum cyminum extract. The composition demonstrated hepatoprotective performance including reductions in SGOT, SGPT, ALP and bilirubin.
Disclaimer: Curated by HT Syndication.
